Viewing SEC Facts Units
Company Name:
Edgewise Therapeutics, Inc.
CIK:
1710072
Start Filing Date:
2023-01-01
End Filing Date:
2022-09-16
ACCN:
0001558370-23-009268
Value:
$ 13,372,093
Value Error:
$ None
Created By:
Date Filed:
2023-05-11
FY:
2023
Fiscal Period:
Q1
Frame:
CY2023Q1I
Type:
us-gaap
Form:
10-Q
Units:
shares